| Year |
Citation |
Score |
| 2022 |
Migliorati M, Manrique C, Rahrah M, Escoffier G, El Ahmadi A, Girard SD, Khrestchatisky M, Rivera S, Baranger K, Roman FS. The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36093693 DOI: 10.3233/JAD-220281 |
0.31 |
|
| 2022 |
Pilat D, Paumier JM, García-González L, Louis L, Stephan D, Manrique C, Khrestchatisky M, Di Pasquale E, Baranger K, Rivera S. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease. Journal of Neuroinflammation. 19: 65. PMID 35277173 DOI: 10.1186/s12974-022-02407-z |
0.452 |
|
| 2021 |
Arnst N, Belio-Mairal P, García-González L, Arnaud L, Greetham L, Nivet E, Rivera S, Dityatev A. Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes. Cells. 10. PMID 34359875 DOI: 10.3390/cells10071705 |
0.395 |
|
| 2021 |
García-González L, Paumier JM, Louis L, Pilat D, Bernard A, Stephan D, Jullien N, Checler F, Nivet E, Khrestchatisky M, Baranger K, Rivera S. MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21727. PMID 34117802 DOI: 10.1096/fj.202100593R |
0.403 |
|
| 2020 |
Zipfel P, Rochais C, Baranger K, Rivera S, Dallemagne P. Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges. Journal of Medicinal Chemistry. PMID 32459966 DOI: 10.1021/Acs.Jmedchem.0C00352 |
0.495 |
|
| 2019 |
Rochais C, Lecoutey C, Hamidouche K, Giannoni P, Gaven F, Cem E, Mignani S, Baranger K, Freret T, Bockaert J, Rivera S, Boulouard M, Dallemagne P, Claeysen S. Donecopride, a Swiss army knife with potential interest against Alzheimer's disease. British Journal of Pharmacology. PMID 31881553 DOI: 10.1111/Bph.14964 |
0.39 |
|
| 2019 |
García-González L, Pilat D, Baranger K, Rivera S. Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP. Frontiers in Aging Neuroscience. 11: 244. PMID 31607898 DOI: 10.3389/Fnagi.2019.00244 |
0.53 |
|
| 2019 |
Baranger K, van Gijsel-Bonnello M, Stephan D, Carpentier W, Rivera S, Khrestchatisky M, Gharib B, De Reggi M, Benech P. Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 31267473 DOI: 10.1007/S13311-019-00754-Z |
0.424 |
|
| 2019 |
Rivera S, García-González L, Khrestchatisky M, Baranger K. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders. Cellular and Molecular Life Sciences : Cmls. PMID 31197405 DOI: 10.1007/S00018-019-03178-2 |
0.462 |
|
| 2019 |
Rivera S. Metalloproteinases in nervous system function and pathology: introduction. Cellular and Molecular Life Sciences : Cmls. PMID 31175371 DOI: 10.1007/S00018-019-03172-8 |
0.358 |
|
| 2018 |
Paumier JM, Py NA, García-González L, Bernard A, Stephan D, Louis L, Checler F, Khrestchatisky M, Baranger K, Rivera S. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201801076R. PMID 30332299 DOI: 10.1096/Fj.201801076R |
0.529 |
|
| 2017 |
Baranger K, Giannoni P, Girard SD, Girot S, Gaven F, Stephan D, Migliorati M, Khrestchatisky M, Bockaert J, Marchetti-Gauthier E, Rivera S, Claeysen S, Roman FS. Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease. Neuropharmacology. PMID 28844596 DOI: 10.1016/J.Neuropharm.2017.08.031 |
0.438 |
|
| 2017 |
van Gijsel-Bonnello M, Baranger K, Benech P, Rivera S, Khrestchatisky M, de Reggi M, Gharib B. Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine. Plos One. 12: e0175369. PMID 28410378 DOI: 10.1371/Journal.Pone.0175369 |
0.381 |
|
| 2016 |
Baranger K, Bonnet AE, Girard SD, Paumier JM, García-González L, Elmanaa W, Bernard A, Charrat E, Stephan D, Bauer C, Moschke K, Lichtenthaler SF, Roman FS, Checler F, Khrestchatisky M, ... Rivera S, et al. MT5-MMP Promotes Alzheimer's Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro. Frontiers in Molecular Neuroscience. 9: 163. PMID 28119565 DOI: 10.3389/Fnmol.2016.00163 |
0.556 |
|
| 2016 |
Baranger K, Khrestchatisky M, Rivera S. MT5-MMP, just a new APP processing proteinase in Alzheimer's disease? Journal of Neuroinflammation. 13: 167. PMID 27349644 DOI: 10.1186/S12974-016-0633-4 |
0.544 |
|
| 2016 |
Giannoni P, Arango-Lievano M, Neves ID, Rousset MC, Barranger K, Rivera S, Jeanneteau F, Claeysen S, Marchi N. Cerebrovascular pathology during the progression of experimental Alzheimer's disease. Neurobiology of Disease. PMID 26774030 DOI: 10.1016/J.Nbd.2016.01.001 |
0.404 |
|
| 2015 |
Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, Py NA, Bernard A, Bauer C, Charrat E, Moschke K, Seiki M, Vignes M, Lichtenthaler SF, Checler F, ... ... Rivera S, et al. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease. Cellular and Molecular Life Sciences : Cmls. PMID 26202697 DOI: 10.1007/S00018-015-1992-1 |
0.728 |
|
| 2015 |
Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, Py NA, Bernard A, Bauer C, Charrat E, Moschke K, Seiki M, Vignes M, Lichtenthaler SF, Checler F, ... ... Rivera S, et al. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease Cellular and Molecular Life Sciences. DOI: 10.1007/s00018-015-1992-1 |
0.709 |
|
| 2014 |
Baranger K, Rivera S, Liechti FD, Grandgirard D, Bigas J, Seco J, Tarrago T, Leib SL, Khrestchatisky M. Endogenous and synthetic MMP inhibitors in CNS physiopathology. Progress in Brain Research. 214: 313-51. PMID 25410364 DOI: 10.1016/B978-0-444-63486-3.00014-1 |
0.46 |
|
| 2014 |
Py NA, Bonnet AE, Bernard A, Marchalant Y, Charrat E, Checler F, Khrestchatisky M, Baranger K, Rivera S. Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP. Frontiers in Aging Neuroscience. 6: 247. PMID 25278878 DOI: 10.3389/Fnagi.2014.00247 |
0.712 |
|
| 2014 |
Landel V, Baranger K, Virard I, Loriod B, Khrestchatisky M, Rivera S, Benech P, Féron F. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Molecular Neurodegeneration. 9: 33. PMID 25213090 DOI: 10.1186/1750-1326-9-33 |
0.343 |
|
| 2014 |
Thevenard J, Verzeaux L, Devy J, Etique N, Jeanne A, Schneider C, Hachet C, Ferracci G, David M, Martiny L, Charpentier E, Khrestchatisky M, Rivera S, Dedieu S, Emonard H. Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities. Plos One. 9: e103839. PMID 25075518 DOI: 10.1371/Journal.Pone.0103839 |
0.414 |
|
| 2014 |
Girard SD, Jacquet M, Baranger K, Migliorati M, Escoffier G, Bernard A, Khrestchatisky M, Féron F, Rivera S, Roman FS, Marchetti E. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease. Hippocampus. 24: 762-72. PMID 24596271 DOI: 10.1002/Hipo.22267 |
0.397 |
|
| 2013 |
Giannoni P, Gaven F, de Bundel D, Baranger K, Marchetti-Gauthier E, Roman FS, Valjent E, Marin P, Bockaert J, Rivera S, Claeysen S. Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease. Frontiers in Aging Neuroscience. 5: 96. PMID 24399967 DOI: 10.3389/Fnagi.2013.00096 |
0.368 |
|
| 2013 |
Crouzin N, Baranger K, Cavalier M, Marchalant Y, Cohen-Solal C, Roman FS, Khrestchatisky M, Rivera S, Féron F, Vignes M. Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus. Plos One. 8: e74667. PMID 24069328 DOI: 10.1371/Journal.Pone.0074667 |
0.666 |
|
| 2013 |
Ould-Yahoui A, Sbai O, Baranger K, Bernard A, Gueye Y, Charrat E, Clément B, Gigmes D, Dive V, Girard SD, Féron F, Khrestchatisky M, Rivera S. Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells. Cell Transplantation. 22: 993-1010. PMID 23043957 DOI: 10.3727/096368912X657468 |
0.445 |
|
| 2013 |
Girard SD, Baranger K, Gauthier C, Jacquet M, Bernard A, Escoffier G, Marchetti E, Khrestchatisky M, Rivera S, Roman FS. Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 33: 781-96. PMID 23042214 DOI: 10.3233/Jad-2012-120982 |
0.43 |
|
| 2012 |
Marchalant Y, Baranger K, Wenk GL, Khrestchatisky M, Rivera S. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? Journal of Neuroinflammation. 9: 10. PMID 22248015 DOI: 10.1186/1742-2094-9-10 |
0.677 |
|
| 2011 |
Wójcik-Stanaszek L, Sypecka J, Szymczak P, Ziemka-Nalecz M, Khrestchatisky M, Rivera S, Zalewska T. The potential role of metalloproteinases in neurogenesis in the gerbil hippocampus following global forebrain ischemia. Plos One. 6: e22465. PMID 21799862 DOI: 10.1371/Journal.Pone.0022465 |
0.4 |
|
| 2011 |
Gueye Y, Ferhat L, Sbai O, Bianco J, Ould-Yahoui A, Bernard A, Charrat E, Chauvin JP, Risso JJ, Féron F, Rivera S, Khrestchatisky M. Trafficking and secretion of matrix metalloproteinase-2 in olfactory ensheathing glial cells: A role in cell migration? Glia. 59: 750-70. PMID 21360755 DOI: 10.1002/Glia.21146 |
0.419 |
|
| 2011 |
Rivera S. F5-04-05: The MMP/TIMP system in Alzheimer's disease Alzheimer's & Dementia. 7: S813-S813. DOI: 10.1016/j.jalz.2011.05.2347 |
0.348 |
|
| 2010 |
Sbai O, Ould-Yahoui A, Ferhat L, Gueye Y, Bernard A, Charrat E, Mehanna A, Risso JJ, Chauvin JP, Fenouillet E, Rivera S, Khrestchatisky M. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes. Glia. 58: 344-66. PMID 19780201 DOI: 10.1002/glia.20927 |
0.353 |
|
| 2009 |
Ould-yahoui A, Tremblay E, Sbai O, Ferhat L, Bernard A, Charrat E, Gueye Y, Lim NH, Brew K, Risso JJ, Dive V, Khrestchatisky M, Rivera S. A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons. Plos One. 4: e8289. PMID 20011518 DOI: 10.1371/Journal.Pone.0008289 |
0.347 |
|
| 2008 |
Sbai O, Ferhat L, Bernard A, Gueye Y, Ould-Yahoui A, Thiolloy S, Charrat E, Charton G, Tremblay E, Risso JJ, Chauvin JP, Arsanto JP, Rivera S, Khrestchatisky M. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Molecular and Cellular Neurosciences. 39: 549-68. PMID 18817873 DOI: 10.1016/J.Mcn.2008.08.004 |
0.444 |
|
| 2006 |
Chaillan FA, Rivera S, Marchetti E, Jourquin J, Werb Z, Soloway PD, Khrestchatisky M, Roman FS. Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice. Behavioural Brain Research. 173: 191-8. PMID 16860884 DOI: 10.1016/J.Bbr.2006.06.020 |
0.336 |
|
| 2006 |
Ogier C, Bernard A, Chollet AM, LE Diguardher T, Hanessian S, Charton G, Khrestchatisky M, Rivera S. Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia. 54: 272-84. PMID 16845676 DOI: 10.1002/Glia.20349 |
0.349 |
|
| 2005 |
Jourquin J, Tremblay E, Bernard A, Charton G, Chaillan FA, Marchetti E, Roman FS, Soloway PD, Dive V, Yiotakis A, Khrestchatisky M, Rivera S. Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. The European Journal of Neuroscience. 22: 2569-78. PMID 16307599 DOI: 10.1111/j.1460-9568.2005.04426.x |
0.307 |
|
| 2004 |
Rivera S, Jourquin J, Ogier C, Bernard A, Charton G, Tremblay E, Khrestchatisky M. [The MMP/TIMP system in the nervous system]. Mã©Decine Sciences : M/S. 20: 55-60. PMID 14770364 DOI: 10.1051/medsci/200420155 |
0.357 |
|
| 2003 |
Jourquin J, Tremblay E, Décanis N, Charton G, Hanessian S, Chollet AM, Le Diguardher T, Khrestchatisky M, Rivera S. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. The European Journal of Neuroscience. 18: 1507-17. PMID 14511330 DOI: 10.1046/J.1460-9568.2003.02876.X |
0.339 |
|
| 2003 |
Khrestchatisky M, Jourquin J, Ogier C, Charton G, Bernard A, Tremblay E, Rivera S. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system]. Journal De La Sociã©Tã© De Biologie. 197: 133-44. PMID 12910628 |
0.373 |
|
| 2002 |
Rivera S, Ogier C, Jourquin J, Timsit S, Szklarczyk AW, Miller K, Gearing AJ, Kaczmarek L, Khrestchatisky M. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. The European Journal of Neuroscience. 15: 19-32. PMID 11860503 DOI: 10.1046/j.0953-816x.2001.01838.x |
0.309 |
|
| Show low-probability matches. |